Arrowhead Pharmaceuticals Inc’s filing revealed that its Director OLUKOTUN ADEOYE Y unloaded Company’s shares for reported $20139.0 on Jan 23 ’25. In the deal valued at $21.00 per share,959 shares were sold. As a result of this transaction, OLUKOTUN ADEOYE Y now holds 35,781 shares worth roughly $ 0.73 million.
Then, OLUKOTUN ADEOYE Y bought 959 shares, generating $20,108 in total proceeds.
Before that, Hamilton James C sold 32,729 shares. Arrowhead Pharmaceuticals Inc shares valued at $648,824 were divested by the Chief Discovery/Trans Medicine at a price of $19.82 per share. As a result of the transaction, Hamilton James C now holds 272,122 shares, worth roughly $5.56 million.
Goldman initiated its Arrowhead Pharmaceuticals Inc [ARWR] rating to a Neutral in a research note published on June 05, 2024; the price target was $31. A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. Citigroup began covering ARWR with “Neutral” recommendation on September 19, 2023. TD Cowen started covering the stock on July 21, 2023. It rated ARWR as “an Outperform”.
Price Performance Review of ARWR
On Tuesday, Arrowhead Pharmaceuticals Inc [NASDAQ:ARWR] saw its stock jump 2.46% to $20.44. Over the last five days, the stock has gained 2.61%. Arrowhead Pharmaceuticals Inc shares have risen nearly 8.72% since the year began. Nevertheless, the stocks have fallen -31.02% over the past one year. While a 52-week high of $36.72 was reached on 02/07/25, a 52-week low of $17.05 was recorded on 02/12/25. SMA at 50 days reached $20.24, while 200 days put it at $22.51.
Levels Of Support And Resistance For ARWR Stock
The 24-hour chart illustrates a support level at 20.04, which if violated will result in even more drops to 19.64. On the upside, there is a resistance level at 20.80. A further resistance level may holdings at 21.16. The Relative Strength Index (RSI) on the 14-day chart is 54.23, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.09, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 32.79%. Stochastics %K at 59.56% indicates the stock is a holding.
